HIKAL
Back to Balance Sheet
|
HIKAL Last 5 Year Total Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹2,806 Cr | ₹2,764 Cr | ₹2,385 Cr | ₹2,328 Cr | ₹2,016 Cr |
What is the latest Total Liabilities ratio of HIKAL ?
| Year | Total Liabilities |
|---|---|
| Mar2025 | ₹2,806 Cr |
| Mar2024 | ₹2,764 Cr |
| Mar2023 | ₹2,385 Cr |
| Mar2022 | ₹2,328 Cr |
| Mar2021 | ₹2,016 Cr |
How is Total Liabilities of HIKAL Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹2,806 Cr | 1.55 | |
| Mar2024 | ₹2,764 Cr | 15.85 | |
| Mar2023 | ₹2,385 Cr | 2.47 | |
| Mar2022 | ₹2,328 Cr | 15.49 | |
| Mar2021 | ₹2,016 Cr | - | |
Compare Total Liabilities of peers of HIKAL
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| HIKAL | ₹2,308.2 Cr | -4.5% | -17.5% | -43.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹390,828.0 Cr | 1.2% | -5.3% | -5.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹158,227.0 Cr | -3.9% | -6% | 11.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹135,045.0 Cr | 0.9% | 3.7% | 20.5% | Stock Analytics | |
| CIPLA | ₹105,961.0 Cr | -1.2% | -12.6% | -6.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,682.5 Cr | -3.4% | -5.7% | 0.3% | Stock Analytics | |
HIKAL Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| HIKAL | -4.5% |
-17.5% |
-43.7% |
| SENSEX | -0.2% |
-4.2% |
8.4% |
You may also like the below Video Courses